These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4268896)

  • 41. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
    Menys VC; Davies JA
    Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hemostatic system.
    Stassen JM; Arnout J; Deckmyn H
    Curr Med Chem; 2004 Sep; 11(17):2245-60. PubMed ID: 15379710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
    Reddy KN; Cercek B; Lew AS; Ganz W
    Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interactions between thrombolytic agents and platelets: effects of plasmin on platelet glycoproteins Ib and IIb/IIIa.
    Hoffmann JJ; Janssen WC
    Thromb Res; 1992 Sep; 67(6):711-9. PubMed ID: 1440536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EPSILON-AMINOCAPROIC ACID AND OTHER INHIBITORS OF FIBRINOLYSIS.
    MCNICOL GP; DOUGLAS AS
    Br Med Bull; 1964 Sep; 20():233-9. PubMed ID: 14209764
    [No Abstract]   [Full Text] [Related]  

  • 46. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
    Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
    Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K
    Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel plasmin inhibitors released from bovine platelets during aggregation.
    Shimonaka M; Kojima S; Hagiwara H; Inada Y
    Thromb Res; 1985 Aug; 39(4):419-27. PubMed ID: 2931857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction.
    Smith JB; Ingerman C; Kocsis JJ; Silver MJ
    J Clin Invest; 1974 May; 53(5):1468-72. PubMed ID: 4825236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of cephalothin and penicillin G on platelet function in vitro.
    Cazenave J-P ; Guccione MA; Packham MA; Mustard JF
    Br J Haematol; 1977 Jan; 35(1):135-52. PubMed ID: 869992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival.
    Reimers HJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    Br J Haematol; 1973 Nov; 25(5):675-89. PubMed ID: 4356665
    [No Abstract]   [Full Text] [Related]  

  • 53. Short communication: possible association of newly absorbed serotonin with nonmetabolic, granule-located adenine nucleotides in human blood platelets.
    Holmsen H; Setkowsky CA; Day HJ
    Blood; 1975 Mar; 45(3):413-6. PubMed ID: 1115836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time course of platelet aggregation during thrombolytic treatment of massive pulmonary embolism.
    Mühl D; Füredi R; Gecse K; Ghosh S; Falusi B; Bogár L; Roth E; Lantos J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):661-7. PubMed ID: 17890954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions.
    Adelman B; Michelson AD; Loscalzo J; Greenberg J; Handin RI
    Blood; 1985 Jan; 65(1):32-40. PubMed ID: 3155489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors responsible for ADP-induced release reaction of human platelets.
    Mustard JF; Perry DW; Kinlough-Rathbone RL; Packham MA
    Am J Physiol; 1975 Jun; 228(6):1757-65. PubMed ID: 50744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.
    Joist JH; Niewiarowski S; Nath N; Mustard JF
    J Lab Clin Med; 1976 Apr; 87(4):659-69. PubMed ID: 131845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measurement of fibrinogen concentrations in suspensions of washed rabbit and human platelets by radioimmunoassays.
    Harfenist EJ; Wrana JL; Packham MA; Mustard JF
    Thromb Haemost; 1985 Feb; 53(1):110-5. PubMed ID: 3992511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.